bioMerieux (BMXMF)
(Delayed Data from OTC)
$105.69 USD
+0.69 (0.66%)
Updated Apr 23, 2024 02:30 PM ET
4-Sell of 5 4
C Value B Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 6/13/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.67 |
Earnings ESP
|
NA |
---|---|
Current Year | 4.43 |
Next Year | 5.03 |
EPS (TTM) | NA |
P/E (F1) | 23.86 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 4.19B | 4.49B |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 4.19B | 4.49B |
Low Estimate | NA | NA | 4.19B | 4.49B |
Year ago Sales | NA | NA | 3.98B | 4.19B |
Year over Year Growth Est. | NA | NA | 10.83% | 7.16% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 4.43 | 5.03 |
# of Estimates | NA | NA | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | NA | NA | 4.43 | 5.03 |
Low Estimate | NA | NA | 4.43 | 5.03 |
Year ago EPS | NA | NA | 3.26 | 4.43 |
Year over Year Growth Est. | NA | NA | 35.89% | 13.54% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | 0 |
Up Last 30 Days | NA | NA | 0 | 1 |
Up Last 60 Days | NA | NA | 0 | 0 |
Down Last 7 Days | NA | NA | 0 | 0 |
Down Last 30 Days | NA | NA | 1 | 0 |
Down Last 60 Days | NA | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | 4.43 | 5.03 |
7 Days Ago | NA | NA | 4.43 | 5.03 |
30 Days Ago | NA | NA | 4.52 | 4.99 |
60 Days Ago | NA | NA | NA | NA |
90 Days Ago | NA | NA | NA | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | 4.43 | 5.03 |
Zacks Consensus Estimate | NA | NA | 4.43 | 5.03 |
Earnings ESP | NA | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | NA | NA | NA | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more